R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma
NCT00144755
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large Cell Lymphoma
Interventions
DRUG:
Darbepoetin alfa
Sponsor
Lymphoma Study Association
Collaborators
[object Object]